<?xml version="1.0" encoding="UTF-8"?>
<p>This multicenter and prospective study was conducted in Korea between March 2012 and August 2012. The 1603 specimens were collected from clinically healthy adolescents and adults above 15 years old in five geographically distant hospitals (The Catholic University of Korea, Seoul St. Mary’s Hospital, Wonju Severance Christian Hospital, Inha University Hospital, Jeonbuk National University Hospital, and Chungnam National University Hospital) in Korea—Seoul as inland capital, Wonju as mountainous terrain, Incheon as a port city, Jeonju as plain ground, and Daejeon as middle inland (
 <xref ref-type="fig" rid="vaccines-08-00328-f001">Figure 1</xref>). Blood samples were collected from each of more than 100 specimens at every age from the age of 15 to 19 years and at every 5 ages of interval from the age group of 20 to 69 years; 87 specimens were obtained over 70 years of age. The subjects with impaired immunologic function, malignancy, blood derivative use, immunosuppressant use, or other immune-modifying drug use were excluded. All the samples were obtained after written informed consent was obtained from each participant. The study protocol was approved by the Institutional Review Board of Inha University Hospital (IUH-IRB-12-09-088), as well as an independent review board at each study site.
</p>
